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Abstract
To estimate endemic areas for Crimean-Congo haemorrhagic fever (CCHF) in Greece, a country-wide seroepidemiological study was
conducted, and 1611 human sera were prospectively collected along with data regarding possible risk factors for acquisition of infection,
and tested for CCHF virus IgG antibodies by ELISA. The overall seroprevalence was 4.2%, with signiﬁcant differences among prefec-
tures, ranging from 0 to 27.5%. Multivariate analysis revealed that slaughtering and agricultural activities were signiﬁcant risk factors for
CCHFV seropositivity. The signiﬁcantly high seroprevalence in speciﬁc prefectures, together with the extremely low number of CCHF
cases, suggest that this phenomenon might be strain-related.
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Abstract
We compared the rate and extent of anidulafungin’s and ﬂuconazole’s activity in neutropenic and non-neutropenic mice with Candida
albicans invasive candidiasis. In immunocompetent mice, anidulafungin signiﬁcantly improved survival vs. controls and ﬂuconazole, and sig-
niﬁcant reductions in (1 ﬁ 3)-b-D-glucan and fungal burden were observed. In neutropenic animals, the highest doses of anidulafungin
(5 mg/kg) and ﬂuconazole (10 mg/kg) also improved survival and reduced fungal burden. However, there were no differences in survival
between these antifungals as anidulafungin’s activity was attenuated in this model. These results demonstrate that the extent of anidula-
fungin in vivo efﬁcacy may be dependent on host immune status.
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Characterization of clinical strains of Aspergillus terreus complex: molecular identiﬁcation
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Abstract
We used molecular techniques to analyse 87 (n = 70 patients) Aspergillus terreus complex isolates, all of which were identiﬁed as A. terre-
us sensu stricto. The antifungal susceptibilities determined with CLSI M38-A2 (and Etest for amphotericin B) and expressed as mg/L for
range of MIC/MIC90/geometric mean were as follows: itraconazole, 0.25–2/2/1.097; voriconazole, 0.125–2/2/1.176; posaconazole, 0.25–
1/1/0.836; amphotericin B CLSI, 4–32/16/9.689; and Etest, 0.75–64/6/3.106. The MICs for amphotericin B were signiﬁcantly higher than
those found for the triazoles.
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Abstract
In this retrospective observational study covering 1998 to 2008, 32 patients (mean age: 7.50 years) were identiﬁed that had 35 episodes
of candidaemia (0.47 cases/1000 hospital discharges). Cancer/allogeneic haematopoietic stem cell transplantation (43%) and congenital
malformations/syndromes (21%) were the predominant underlying conditions. Central venous catheterization (90%), a history of anti-
bacterial therapy (69%) and previous bacteraemia (54%) were frequent comorbidities. Candida albicans (46%) was most common, fol-
lowed by Candida parapsilosis (17%) and Candida glabrata (14%). Resistance was infrequent and limited to non-albicans Candida spp. The
30-day and 100-day mortality rates were 11.4%.
CMI Online-only Abstracts 203
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases, CMI, 18, 202–204
Which anatomical sites should be sampled for screening of methicillin-resistant
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Abstract
The nose is the anatomical site usually recommended for methicillin-resistant Staphylococcus aureus (MRSA) screening. Other sites are
also recommended, but are more controversial. We showed that the sensitivities of MRSA detection from nasal swabs alone were 48%
and 62% by culture or by rapid PCR test, respectively. These percentages increased to 79% and 92% with the addition of groin swabs,
and to 96% and 99% with the addition of groin and throat swabs. In conclusion, neither by culture nor by rapid PCR test is nose sam-
pling alone sufﬁcient for MRSA detection. Additional anatomical sites should include at least the groin and throat.
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Abstract
Screening 155 carbapenem non-susceptible Acinetobacter baumannii strains recovered in Abu Dhabi hospitals identiﬁed two metallo-ß-lac-
tamase blaNDM gene-carrying isolates. They were isolated 4 months apart from the urine of a cancer patient previously treated in Egypt,
Lebanon and in the United Arab Emirates. They were clonally related and carried the blaNDM-2 gene recently identiﬁed in A. baumannii
in Egypt and Israel. Sequences surrounding the blaNDM-2 gene showed signiﬁcant similarities with those associated with blaNDM-1 in En-
terobacteriaceae and A. baumannii. Repeated isolation of blaNDM-2-positive A. baumannii in the Middle East raises the possibility of the
local emergence and spread of a unique clone.
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